東方創業(600278.SH)擬與控股股東旗下公司、沈德海合資設立醫院管理公司
格隆匯4月3日丨東方創業(600278.SH)公佈,公司擬與控股股東東方國際(集團)有限公司的全資子公司東方國際集團上海投資有限公司(“投資公司”)以及自然人沈德海合資設立醫院管理公司,由醫院管理公司全資設立微創中醫醫院,打造一家以沈德海的“痔上黏膜血管結紮懸吊術”治療環狀混合痔非專利技術為特色的肛腸專科營利性醫院,並擬委託上海市黃浦區香山中醫醫院(“香山中醫院”)進行醫療管理和學科共建。
醫院管理公司註冊資本2000萬元,其中投資公司擬以現金出資1020萬元,佔比51%;公司擬現金出資480萬元,佔比24%;自然人沈德海出資500萬元(其中25萬元為現金出資,475萬元為無形資產出資),佔比25%。
公司將大健康產業作為未來發展的重點方向,此次投資是公司對醫療健康產業的有效探索,有利於公司進一步發展大健康產業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.